94,900 results on '"Bladder cancer"'
Search Results
2. A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
3. Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
4. Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
5. A Study of Pembrolizumab (MK-3475) Plus V940 in Participants With Bladder Cancer Post-Radical Resection (V940-005)
6. ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States (ABLE-41)
7. Quality of Life in Patients With Bladder Cancer
8. En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
9. A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
10. Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer (BLAST)
11. Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
12. Urine DNA Methylation Detection for Hematuria Evaluation
13. Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
14. A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
15. Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers (ARC-25)
16. Bintrafusp Alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
17. A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
18. Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients
19. A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) (SunRISe-3)
20. Connecting Audio and Radio Sensing Systems to Improve Care at Home (AURA)
21. Tempus Priority Study: A Pan-tumor Observational Study
22. Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (PETRA)
23. Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (AGADIR)
24. Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
25. Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
26. Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
27. A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.
28. Physical Therapy in Pre-cystectomy Patients
29. A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
30. Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers (GUB-BCR-001)
31. Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
32. Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
33. Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) (PreAct)
34. A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
35. Intracorporeal vs Extracorporeal Urinary Diversion After Robot Assisted Radical Cystectomy
36. Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
37. Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy
38. A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
39. A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
40. A Study of MGC026 in Participants With Advanced Solid Tumors
41. Improving Care for Rural Patients With Solid Tumors
42. A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
43. Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia (HyBla_RCT)
44. Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer (STAR-EV)
45. Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
46. Avelumab and Radiation in Muscle-Invasive Bladder Cancer
47. Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
48. 3 Tesla MRI in Patients With Bladder Cancer
49. Bladder Cancer and exeRcise Training During intraVesical thErapy (BRAVE)
50. Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.